Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Robert-Roessle-Str. 10 , Building D80, Berlin, 13125, DE
Integrated approach simplifies development, reduces risk, and supports scalable manufacturing.
By: Charlie Sternberg
Aims to deepen its sterile fill-finish and advanced drug delivery capabilities.
AI will help build a treatment planning platform for convection enhanced delivery, or CED.
By: Patrick Lavery
Enables more flexible and customizable dosing options for critical oral drug therapies, including modified release drug delivery.
Modified Release tablets are designed to control the rate, timing, and location of drug release within the gastrointestinal tract for either prolonged or optimal drug delivery.
Released By Upperton
Expands drug delivery opportunity with Surf Bio’s hyperconcentration technology.
By: Kristin Brooks
Agreement provides Takeda with exclusive access to ENHANZE drug delivery technology.
Will support Skye's evaluation of higher nimacimab subcutaneous doses for the treatment of obesity.
Topical, transdermal, and long-acting injectables are moving fast, and expectations for purity, performance, and regulatory readiness are higher than ever.
Released By gChem
Marks a strategic milestone in Halozyme’s mission to expand its drug delivery technology offerings to biopharma companies.
Merus has licensed Halozyme's ENHANZE drug delivery technology for the development and potential commercialization of subcutaneous administration of petosemtamab.
Multi-million investment includes installation of an ISO 8 cleanroom environment, fully equipped for injection molding and automated assembly operations.
Nasal drug delivery is now emerging as a promising route for the rapid delivery of certain classes of molecules.
Expands and diversifies its drug delivery technology offerings to the biopharma industry.
The pulmonary delivery route is of increasing interest to those looking to deliver more complex molecules, such as biologics, into the lung for either local or potentially systemic delivery.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
